These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 29407910

  • 1. Comparative solution equilibrium and structural studies of half-sandwich ruthenium(II)(η6-toluene) complexes of picolinate derivatives.
    Poljarević JM, Tamás Gál G, May NV, Spengler G, Dömötör O, Savić AR, Grgurić-Šipka S, Enyedy ÉA.
    J Inorg Biochem; 2018 Apr; 181():74-85. PubMed ID: 29407910
    [Abstract] [Full Text] [Related]

  • 2. Comparative solution equilibrium studies of antitumor ruthenium(η6-p-cymene) and rhodium(η5-C5Me5) complexes of 8-hydroxyquinolines.
    Dömötör O, Pape VFS, May NV, Szakács G, Enyedy ÉA.
    Dalton Trans; 2017 Mar 27; 46(13):4382-4396. PubMed ID: 28287667
    [Abstract] [Full Text] [Related]

  • 3. Organometallic Ru(II), Rh(III) and Re(I) complexes of sterane-based bidentate ligands: synthesis, solution speciation, interaction with biomolecules and anticancer activity.
    Pivarcsik T, Kiss MA, Rapuš U, Kljun J, Spengler G, Frank É, Turel I, Enyedy ÉA.
    Dalton Trans; 2024 Mar 12; 53(11):4984-5000. PubMed ID: 38406993
    [Abstract] [Full Text] [Related]

  • 4. Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivity.
    Dömötör O, Aicher S, Schmidlehner M, Novak MS, Roller A, Jakupec MA, Kandioller W, Hartinger CG, Keppler BK, Enyedy ÉA.
    J Inorg Biochem; 2014 May 12; 134():57-65. PubMed ID: 24556426
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 8-Hydroxyquinoline-Amino Acid Hybrids and Their Half-Sandwich Rh and Ru Complexes: Synthesis, Anticancer Activities, Solution Chemistry and Interaction with Biomolecules.
    Pivarcsik T, Dömötör O, Mészáros JP, May NV, Spengler G, Csuvik O, Szatmári I, Enyedy ÉA.
    Int J Mol Sci; 2021 Oct 19; 22(20):. PubMed ID: 34681939
    [Abstract] [Full Text] [Related]

  • 7. RuII( p-cymene) Compounds as Effective and Selective Anticancer Candidates with No Toxicity in Vivo.
    Lenis-Rojas OA, Robalo MP, Tomaz AI, Carvalho A, Fernandes AR, Marques F, Folgueira M, Yáñez J, Vázquez-García D, López Torres M, Fernández A, Fernández JJ.
    Inorg Chem; 2018 Nov 05; 57(21):13150-13166. PubMed ID: 30339386
    [Abstract] [Full Text] [Related]

  • 8. Hydrolytic behaviour and chloride ion binding capability of [Ru(η6-p-cym)(H2O)3]2+: a solution equilibrium study.
    Bíró L, Farkas E, Buglyó P.
    Dalton Trans; 2012 Jan 07; 41(1):285-91. PubMed ID: 22051630
    [Abstract] [Full Text] [Related]

  • 9. Half-sandwich organometallic Ru and Rh complexes of (N,N) donor compounds: effect of ligand methylation on solution speciation and anticancer activity.
    Mészáros JP, Pape VFS, Szakács G, Németi G, Dénes M, Holczbauer T, May NV, Enyedy ÉA.
    Dalton Trans; 2021 Jun 15; 50(23):8218-8231. PubMed ID: 34032247
    [Abstract] [Full Text] [Related]

  • 10. Solution equilibrium, structural and cytotoxicity studies on Ru(η6-p-cymene) and copper complexes of pyrazolyl thiosemicarbazones.
    Dömötör O, Kiss MA, Gál GT, May NV, Spengler G, Nové M, Gašparović AČ, Frank É, Enyedy ÉA.
    J Inorg Biochem; 2020 Jan 15; 202():110883. PubMed ID: 31689626
    [Abstract] [Full Text] [Related]

  • 11. Solution equilibria of anticancer ruthenium(II)-(η(6)-p-cymene)-hydroxy(thio)pyr(id)one complexes: impact of sulfur vs. oxygen donor systems on the speciation and bioactivity.
    Enyedy EA, Sija E, Jakusch T, Hartinger CG, Kandioller W, Keppler BK, Kiss T.
    J Inorg Biochem; 2013 Oct 15; 127():161-8. PubMed ID: 23721887
    [Abstract] [Full Text] [Related]

  • 12. Reversible pH-Responsive Behavior of Ruthenium(II) Arene Complexes with Tethered Carboxylate.
    Martínez-Peña F, Infante-Tadeo S, Habtemariam A, Pizarro AM.
    Inorg Chem; 2018 May 07; 57(9):5657-5668. PubMed ID: 29688005
    [Abstract] [Full Text] [Related]

  • 13. [(η(6)-p-cymene)Ru(H2O)3](2+) binding capability of aminohydroxamates - A solution and solid state study.
    Parajdi-Losonczi PL, Bényei AC, Kováts É, Timári I, Muchova TR, Novohradsky V, Kasparkova J, Buglyó P.
    J Inorg Biochem; 2016 Jul 07; 160():236-45. PubMed ID: 26971623
    [Abstract] [Full Text] [Related]

  • 14. An 8-hydroxyquinoline-proline hybrid with multidrug resistance reversal activity and the solution chemistry of its half-sandwich organometallic Ru and Rh complexes.
    Mészáros JP, Poljarević JM, Szatmári I, Csuvik O, Fülöp F, Szoboszlai N, Spengler G, Enyedy ÉA.
    Dalton Trans; 2020 Jun 21; 49(23):7977-7992. PubMed ID: 32500882
    [Abstract] [Full Text] [Related]

  • 15. Effect of N,N Coordination and RuII Halide Bond in Enhancing Selective Toxicity of a Tyramine-Based RuII (p-Cymene) Complex.
    Mukherjee A, Acharya S, Purkait K, Chakraborty K, Bhattacharjee A, Mukherjee A.
    Inorg Chem; 2020 May 04; 59(9):6581-6594. PubMed ID: 32295347
    [Abstract] [Full Text] [Related]

  • 16. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J, Tian M, Tian Z, Zhang S, Yan C, Shao C, Liu Z.
    Inorg Chem; 2018 Feb 19; 57(4):1705-1716. PubMed ID: 29400963
    [Abstract] [Full Text] [Related]

  • 17. Highly Cytotoxic Ruthenium(II)-Arene Complexes from Bulky 1-Pyrenylphosphane Ligands.
    Brissos RF, Clavero P, Gallen A, Grabulosa A, Barrios LA, Caballero AB, Korrodi-Gregório L, Pérez-Tomás R, Muller G, Soto-Cerrato V, Gamez P.
    Inorg Chem; 2018 Dec 03; 57(23):14786-14797. PubMed ID: 30444630
    [Abstract] [Full Text] [Related]

  • 18. Promising anticancer mono- and dinuclear ruthenium(III) dithiocarbamato complexes: systematic solution studies.
    Nagy EM, Nardon C, Giovagnini L, Marchiò L, Trevisan A, Fregona D.
    Dalton Trans; 2011 Nov 28; 40(44):11885-95. PubMed ID: 21971872
    [Abstract] [Full Text] [Related]

  • 19. Metal Complexes of a 5-Nitro-8-Hydroxyquinoline-Proline Hybrid with Enhanced Water Solubility Targeting Multidrug Resistant Cancer Cells.
    Pivarcsik T, Pósa V, Kovács H, May NV, Spengler G, Pósa SP, Tóth S, Nezafat Yazdi Z, Özvegy-Laczka C, Ugrai I, Szatmári I, Szakács G, Enyedy ÉA.
    Int J Mol Sci; 2022 Dec 29; 24(1):. PubMed ID: 36614037
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.